Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research in the area of breast cancer reported from L. Ceriani and colleagues
October 16th, 2008
"Tc-99m sestamibi has been reported to accumulate in several tissues with increased metabolism and particularly in solid tumors," investigators in Bellinzona, Switzerland report. "Although the clinical utility of this radiopharmaceutical has been described in primary breast cancer and its axillary involvement, it has not been fully evaluated in local recurrence or distant metastasis. We illustrate the case of a post-mastectomy patient in whom Tc-99m sestamibi single photon emission tomography (SPET) myocardial perfusion scintigraphy, performed to evaluate chest pain mimicking angina, aided in discovering local recurrence of breast cancer in the chest wall," wrote L....
Source: Women's Health Weekly (2008-10-16)
|
